Suppliers / Corden Pharma Bergamo

Corden Pharma Bergamo

Italy 2 duplicate records merged Updated 9 July 2026

Corden Pharma Bergamo is an API manufacturer based in Italy. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 4 molecules. Its most recent recorded inspection, by US FDA, closed on 18 March 2022 as VAI.

4
active US DMFs
2
valid CEPs
2
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 18 March 2022 VAI US FDA
  • 27 September 2018 VAI US FDA
  • 17 June 2016 VAI US FDA
  • 8 November 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Treviglio, Italy Not on file
Italy, Italy 3002806963

What they file, and where

Molecule Regulators Docs
Metronidazole EDQM, US FDA 3
Benzoyl Peroxide SFDA (Saudi Arabia), US FDA 2
Disulfiram US FDA 1
Secnidazole US FDA 1

Also appears on these molecule pages

Benzoyl Peroxide API Metronidazole API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None

Comparing suppliers?

Choose your molecules and target markets. Corden Pharma Bergamo comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 18 March 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability